Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Advisor operating in the Life Science space. If you think a Advisor is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
David Grainger
Chief Scientific Advisor of Medicxi Ventures
Prior to co-founding Medicxi Ventures, David was a venture partner with Index Ventures for four years, having joined the life sciences team in 2012.On behalf of Index, David co-founded Epsilon-3 Bio, Methusalah Health, and XO1 (acquired by Janssen Pharmaceuticals) among other companies. Before joining Index, he founded Funxional Therapeutics and the out-sourced drug developers Total Scientific and RxCelerate. Prior to that, David led an internationally-recognised research group in Cambridge University’s Department of Medicine, where he published more than 80 first author papers in leading journals including Nature, Science and Nature Medicine. David is the Chair of the Translation Awards Committee of the British Heart Foundation. He ran a widely-read blog on life sciences-related topics, DrugBaron, before moving his writings to Forbes.com, where he is a Contributor.David has over 150 patents and patent applications in his name, and holds MA and PhD degrees in Natural Sciences from the University of Cambridge
Follow David Grainger:
About Centessa Pharmaceuticals, Critical Pressure, Forbes, Foundation Institute for 21st Century Medicine, Morphogen-IX, Z Factor: Medicxi is a life sciences-focused investment firm.
Martin Landaluce
Strategic Advisory Board of Broadview Ventures
Martin Landaluce, a member of Broadview’s Strategic Advisory Board, has also been a member of the Fondation Leducq Board of Directors for 10 years, and serves as its treasurer. His responsibilities include the financial management of the Foundation, and the coordination of activities with the Leducq Trust, where he oversees investment and spending policies and handles the legal matters of the Trust and its underlying companies.
Follow Martin Landaluce:
About : Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Kim Fox
Strategic Advisory Board of Broadview Ventures
Kim Fox, MD, a member of Broadview’s Strategic Advisory Board, is a Consultant Cardiologist and Director of Cardiology at the Royal Brompton Hospital and Professor of Clinical Cardiology, Imperial College. Professor Fox has published over 400 papers in leading scientific journals. His expertise is in the understanding, investigation and treatment of angina; he has played a major role in many important international clinical trials (EUROPA, HPS, ASCOT etc) that have revolutionized the treatment of this condition. He is the acknowledged European expert in this field and consequently chairs the Task Force producing the European Angina Guidelines and chairs the committee responsible for the audit for the management of these patients in Europe. Professor Fox has given plenary lectures to National Societies all over the world. He has given the “Finlayson Lecture” to the Royal College of Surgeons in Glasgow, the “St Cyres Lecture” to the British Cardiac Society and the “Andrea Cissalpino Lecture” to the Italian Society of Cardiology. Professor Fox has been elected an honorary member of the French Cardiac Society and Japanese Circulation Society for his services to cardiology.
Follow Kim Fox:
About : Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Kasper Kruse Petersen
Advisor of Airfinity
Follow Kasper Kruse Petersen:
About : Airfinity is a science information and analytics company
Nicholas Lakin
Vice President, Advisory Services of Kinapse
Follow Nicholas Lakin:
About Kinapse: Kinapse provides advisory, capability building and operational services to the life sciences industries.
